Related Experiment Video
Updated: Jun 27, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Nucleoplasmic mobilization of nucleostemin stabilizes MDM2 and promotes G2-M progression and cell survival
Lingjun Meng1, Tao Lin, Robert Y L Tsai
1Center for Cancer and Stem Cell Biology, Alkek Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX 77030, USA.
Abstract:
Nucleolar disassembly occurs during mitosis and nucleolar stress, releasing several MDM2-interactive proteins residing in the nucleolus that share the common activity of p53 stabilization. Here, we demonstrate that mobilization of nucleostemin, a nucleolar protein enriched in cancer and stem cells, has the opposite role of stabilizing MDM2 and suppressing p53 functions. Our results show that nucleostemin increases the protein stability and nucleoplasmic retention of MDM2, and competes with L23 for MDM2 binding. These activities were significantly elevated when nucleostemin is released into the nucleoplasm by mutations that abolish its nucleolar localization or by chemotherapeutic agents that disassemble the nucleoli. Nucleostemin depletion decreases MDM2 protein, increases transcription activity without affecting the level of p53 protein, and triggers G2-M arrest and cell death in U2OS cells but not in H1299 cells. This work reveals that nucleoplasmic relocation of nucleostemin during nucleolar disassembly safeguards the G2-M transit and survival of continuously dividing cells by MDM2 stabilization and p53 inhibition.
Insights
Nucleostemin stabilizes MDM2, inhibiting p53 and promoting cell survival during mitosis. Its relocation from the nucleolus to the nucleoplasm during stress safeguards cell division and survival.
Area of Science:
- Cell Biology
- Molecular Oncology
- Cancer Research
Background:
- Nucleolar disassembly during mitosis and stress releases p53-stabilizing proteins.
- Nucleostemin is a nucleolar protein found in cancer and stem cells.
Purpose of the Study:
- To investigate the role of nucleostemin in regulating MDM2 and p53.
- To understand how nucleostemin's localization affects cell cycle progression and survival.
Main Methods:
- Assessing MDM2 protein stability and localization.
- Investigating nucleostemin's interaction with MDM2.
- Analyzing cell cycle progression and cell death following nucleostemin manipulation.
Main Results:
- Nucleostemin enhances MDM2 stability and nucleoplasmic retention, competing with L23 for binding.
- Nucleostemin relocation to the nucleoplasm increases MDM2 stabilization and p53 inhibition.
- Nucleostemin depletion causes G2-M arrest and cell death in U2OS cells.
Conclusions:
- Nucleoplasmic relocation of nucleostemin during nucleolar disassembly promotes cell survival.
- Nucleostemin stabilizes MDM2 and inhibits p53, facilitating G2-M transit in dividing cells.
More Related Videos
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle